KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1

Q3 2020 13F Holders as of 9/30/2020

Type / Class
Debt / NOTE 3.000%10/1
Number of holders
13
Total Principal
177M
Shares change
-2M
Total reported value, excl. options
$213M
Value change
-$7.31M
Put/Call ratio
0
Number of buys
7
Number of sells
-6
Price
$1.20
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.